InsidersTradesSigma
한미약품 Stock: price and insider trades · South Korea · DART (FSS)
Track the 한미약품 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 한미약품 has logged 2 reports. Market capitalisation: €4,368.3bn. The latest transaction was disclosed on 10 June 2026 (Mixed). Among the most active insiders: 국민연금공단. The full history is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 한미약품 Strong Buy (bullish), based on 12 analysts. Average price target: ₩599,167.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,263 of 28,169 companies
58.3
score / 100
Value45
Quality71
FCF yld1.9%
Earn yld3.4%
EV/EBITDA16.4x
ROE14%
Gross mgn57%
Net mgn11%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 June 2026
About 한미약품
Hanmi Pharmaceutical is a South Korean pharmaceutical company focused on the research and development of drugs. It is listed on the Korea Exchange (XKRX).